Complete mitochondrial DNA sequence analysis in patients with major depressive disorder.

Area of Science:

• Genetics and Molecular Biology
• Neuroscience
• Mitochondrial Biology

Background:

• Major depressive disorder (MDD) is a complex psychiatric condition with multifactorial etiology.
• The role of mitochondrial dysfunction and mitochondrial DNA (mtDNA) mutations in MDD pathogenesis is an emerging area of research.
• Understanding genetic risk factors, including specific mtDNA mutations, is crucial for advancing MDD diagnosis and treatment.

Purpose of the Study:

• To identify specific mitochondrial DNA (mtDNA) mutations associated with major depressive disorder (MDD).
• To evaluate the relationship between mutation burden, functional mutations, and disease risk in MDD patients.
• To investigate the potential protective effects of mitochondrial haplotypes in MDD.

Main Methods:

• Whole mitochondrial genome sequencing was performed on DNA extracted from blood samples of MDD patients and controls.
• Mutation burden analysis included total counts, highly conserved mutations (Conservation Index >75%), and structurally disruptive mutations.
• Mitochondrial haplotypes were analyzed using binary logistic regression to assess disease association and risk.

Main Results:

• While no significant difference in overall mutation counts was found, 16 specific mutation sites were potentially associated with MDD onset.
• A novel mutation, MT-ND1 (m.3536T>G), with a 100% conservation index, was identified and linked to mitochondrial dysfunction.
• Haplotype B4 demonstrated a significant protective association with MDD (P=0.026, AOR=0.228).

Conclusions:

• Specific functional mitochondrial DNA (mtDNA) mutations, rather than solely mutational load, may contribute to major depressive disorder (MDD) development.
• The identified protective role of haplotype B4 suggests it as a potential therapeutic target for MDD.
• Further research is warranted to explore the clinical implications of these findings and validate therapeutic strategies.